Video
Unknown · 0:00
Moderna's first successful personalized cancer vaccine, developed with Merck for melanoma, just hit its Phase 3 primary endpoint after a field-wide track record of over 1,000 failed cancer vaccine trials spanning 20+...
Unknown · 0:00
Moderna's first successful personalized cancer vaccine, developed with Merck for melanoma, just hit its Phase 3 primary endpoint after a field-wide track record of over 1,000 failed cancer vaccine trials spanning 20+...
Redirecting...